Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial

Pakistan likely to be first to complete research in immunoglobulin therapy to treat COVID-19 Scientists at Dow University say ‘severe’ patients who received the treatment had a 100% recovery rate. https://t.co/0v8nhQdQIX https://t.co/y5Qhc2bTeo #COVID

@MalikAshraf3 note that this Hasn't been proven to be effective, or at least there's no public statement for its efficacy as of now https://t.co/QxUTmHskH2